SciTransfer
Organization

MATERIALS RESEARCH CENTER

Ukrainian materials SME specializing in nanomaterials, polymer composites, and biosensors for diagnostics and health applications.

Technology SMEhealthUASME
H2020 projects
5
As coordinator
0
Total EC funding
€529K
Unique partners
51
What they do

Their core work

Materials Research Center is a Ukrainian SME specializing in advanced materials science, with particular strength in nanomaterials, polymer composites, and biosensor development. Their work spans from synthesizing 1D and 2D nanostructures (metal oxides, MXenes, graphene) to applying them in real-world contexts like cancer detection, air quality protection, and oral health diagnostics. They contribute materials expertise and characterization capabilities to international research consortia through the MSCA-RISE staff exchange mechanism.

Core expertise

What they specialise in

Polymer nanocomposites with 2D fillersprimary
1 project

NANO2DAY (their largest project at EUR 243K) focused on multifunctional polymer composites doped with MXene and graphene nanoparticles.

Metal oxide nanostructures for biosensingprimary
1 project

CanBioSe developed 1D photonic metal oxide nanostructures using ALD and electrospinning for early-stage cancer detection.

Microfluidic biosensors and diagnosticsemerging
1 project

SALSETH (EUR 133K) explored bio-inspired sensors and microfluidic chips for saliva-based theranostics of oral diseases.

Nanomaterials for indoor air qualitysecondary
1 project

NANOGUARD2AR applied nanomaterials-based engineering solutions for indoor air safeguarding.

Membrane biophysicssecondary
1 project

assymcurv investigated cell membrane asymmetry and curvature effects on membrane protein function.

Evolution & trajectory

How they've shifted over time

Early focus
Fundamental nanomaterials research
Recent focus
Applied nanostructures for diagnostics

MRC's early H2020 involvement (2016) began with fundamental biophysics and environmental nanomaterials — projects like assymcurv (membrane proteins) and NANOGUARD2AR (indoor air). From 2018 onward, they shifted decisively toward applied nanomaterials with clear diagnostic and industrial purposes: cancer detection via metal oxide nanostructures, functional polymer composites with graphene and MXene, and microfluidic biosensors. The trajectory shows a move from fundamental science toward application-oriented materials development with biomedical and health relevance.

MRC is moving toward biomedical sensing applications built on their nanomaterials expertise, making them a strong fit for future health-tech and diagnostic device consortia.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European20 countries collaborated

MRC exclusively participates as a partner, never as coordinator — consistent with their SME size and the MSCA-RISE format, which emphasizes staff exchange and knowledge transfer. With 51 unique partners across 20 countries from just 5 projects, they operate in large, geographically diverse consortia. This broad network suggests they are well-connected and comfortable working across cultural and institutional boundaries, though the RISE format naturally produces large partner lists.

Despite being based in Ukraine, MRC has collaborated with 51 unique partners across 20 countries — an unusually wide network for an SME with only 5 projects, reflecting the large consortium nature of MSCA-RISE actions.

Why partner with them

What sets them apart

MRC brings Ukrainian materials science expertise into European consortia at competitive cost, with demonstrated capability across both inorganic nanostructures (metal oxides, ALD) and organic/polymer systems (composites, biosensors). Their rare combination of nanofabrication skills and biomedical application knowledge — from graphene composites to microfluidic cancer diagnostics — makes them a versatile materials partner. For consortium builders, they offer a non-EU associated country participant with genuine technical depth, not just a flag-of-convenience partner.

Notable projects

Highlights from their portfolio

  • NANO2DAY
    Their largest funded project (EUR 243K) and most technically ambitious — working with MXene and graphene nanoparticles for multifunctional polymer composites.
  • SALSETH
    Represents their newest direction (started 2019) combining biosensors with microfluidics for saliva-based diagnostics — a commercially promising application area.
  • CanBioSe
    Bridges their nanofabrication expertise (ALD, electrospinning) directly to cancer detection, demonstrating clear translational potential.
Cross-sector capabilities
manufacturing — polymer composites and nanofillers for industrial materialsenvironment — nanomaterials for air quality and pollution controlfood — edible food-based materials and food safety biosensorsdigital — microfluidic lab-on-chip devices and sensor integration
Analysis note: All 5 projects use the MSCA-RISE scheme (staff exchange), so MRC's role is primarily knowledge transfer and researcher mobility rather than leading R&D workpackages. The high partner count (51) and country spread (20) are partly an artifact of the RISE format's large consortia. No website available for independent verification of capabilities. Funding levels are modest, typical for RISE participant contributions. The early projects (assymcurv, NANOGUARD2AR) had no keywords in the dataset, limiting early-period analysis.